2 C
New York
Wednesday, February 1, 2023

It’s Not Over Yet For Oscar Health Inc. (NYSE: OSCR)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Oscar Health Inc. (OSCR) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.02, or -0.66%, to $3.00. The Oscar Health Inc. has recorded 25,969 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Oscar Health, Inc. 2022 Fourth Quarter and Full Year Earnings Conference Call.


Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Stocks Info

Oscar Health Inc. is listed on the NYSE as a member of the Healthcare sector and is a part of the Healthcare Plans industry. At the end of the last regular session, the stock closed at $3.02 and fluctuated between $3.0200 as its day high and $2.6800 as its day low. The current market capitalization of Oscar Health Inc. is $653.62M. A total of 1.7 million shares were traded on the day, compared to an average of 1.82M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, OSCR has seen 11 BUY and 7 SELL insider trades, representing the acquisition of 206,319 and the disposition of 66,729 shares. Over the last 12 months, there were 42 BUYs and 28 SELLs from insiders. Insiders purchased 934,475 shares during that period but sold 274,702.

In the most recent transaction, Quane Alessandrea C. sold 17,456 shares of OSCR for 2.64 per share on Dec 06. After the transaction, the EVP, Chief Insurance Officer now owns 165,801 company shares. In a previous transaction on Dec 06, Blackley Richard Scott sold 31,397 shares at 2.64 per share. OSCR shares that Chief Transformation Officer owns now total 334,750.

Among the insiders who sold shares, Baltrus Victoria disposed of 2,789 shares on Dec 02 at a per-share price of $2.84. This resulted in the Chief Accounting Officer holding 20,673 shares of OSCR after the transaction. In another insider transaction, Weaver Dennis sold 1,624 shares at $2.84 per share on Dec 02. Company shares held by the Chief Clinical Officer now total 27,110.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for OSCR in the last 3 months, the mean price target is $4.19 with high estimates of $7.00 and low estimates of $2.85. In terms of 52-week highs and lows, OSCR has a high of $10.52 and a low of $2.05.

As of this writing, OSCR has an earnings estimate of -$0.73 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.63 per share and a lower estimate of -$0.8. The company reported an EPS of -$0.36 in the last quarter, which was -71.40% lower than expectations of -$0.21.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 7 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OSCR is Overweight with a score of 2.80. A total of 2 analysts rated the stock as Buy while 0 rated it as Overweight while 4 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles